NVCR insider transaction filings
NovoCure Ltd — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-01. Screen NVCR transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | Puri Michal Nath — Chief Human Resources Officer | Grant/award (A): 1,905 @ $11.15 | EDGAR |
| 2026-07-01 | 4 | Ben Arye Barak — General Counsel | Grant/award (A): 1,299 @ $11.15 | EDGAR |
| 2026-07-01 | 4 | Leonard Frank X — Chief Executive Officer | Grant/award (A): 1,905 @ $11.15 | EDGAR |
| 2026-07-01 | 4 | Danziger Asaf — Director | Grant/award (A): 268 @ $11.15 | EDGAR |
| 2026-06-05 | 4 | Stafford Kristin — Director | Grant/award (A): 11,610 @ $0 · Grant/award (A): 16,999 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Ocean Allyson J — Director | Grant/award (A): 11,610 @ $0 · Grant/award (A): 16,999 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Leonard Frank X — Chief Executive Officer | Sale (S): 34,273 @ $17.93 | EDGAR |
| 2026-06-05 | 4 | Madden Martin J. — Director | Grant/award (A): 11,610 @ $0 · Grant/award (A): 16,999 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Scannell Timothy J — Director | Grant/award (A): 11,610 @ $0 · Grant/award (A): 16,999 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | VERNON W ANTHONY — Director | Grant/award (A): 11,610 @ $0 · Grant/award (A): 16,999 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Hung David — Director | Grant/award (A): 11,610 @ $0 · Grant/award (A): 16,999 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | LEUNG GABRIEL — Director | Grant/award (A): 11,610 @ $0 · Grant/award (A): 16,999 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | HILLEMAN JERYL L — Director | Grant/award (A): 11,610 @ $0 · Grant/award (A): 16,999 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Stafford Kristin — Director | Sale (S): 2,945 @ $15.77 | EDGAR |
| 2026-06-03 | 4 | Ocean Allyson J — Director | Sale (S): 2,945 @ $15.77 | EDGAR |
| 2026-06-03 | 4 | Scannell Timothy J — Director | Sale (S): 2,945 @ $15.77 | EDGAR |
| 2026-06-03 | 4 | VERNON W ANTHONY — Director | Sale (S): 2,945 @ $15.77 | EDGAR |
| 2026-06-03 | 4 | Hung David — Director | Sale (S): 2,945 @ $15.77 | EDGAR |
| 2026-06-03 | 4 | LEUNG GABRIEL — Director | Sale (S): 2,945 @ $15.77 | EDGAR |
| 2026-06-03 | 4 | HILLEMAN JERYL L — Director | Sale (S): 2,945 @ $15.77 | EDGAR |
| 2026-04-28 | 4 | VERNON W ANTHONY — Director | Option exercise (M): 21,500 @ $11.39 · Option exercise (M): 21,500 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | Brackmann Christoph — Chief Financial Officer | Grant/award (A): 55,137 @ $0 · Sale (S): 6,412 @ $13.31 · Grant/award (A): 80,674 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | Paravasthu Mukund — Chief Operating Officer | Grant/award (A): 45,112 @ $0 · Sale (S): 5,377 @ $13.31 · Sale (S): 43,246 @ $13.77 · Grant/award (A): 7,518 (derivative) @ $0 · Grant/award (A): 58,488 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | Leupin Nicolas — Former Chief Medical Officer | Sale (S): 1,100 @ $13.31 | EDGAR |
| 2026-03-05 | 4 | Puri Michal Nath — Chief Human Resources Officer | Grant/award (A): 40,100 @ $0 · Sale (S): 1,100 @ $13.31 · Grant/award (A): 58,672 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | Ben Arye Barak — General Counsel | Grant/award (A): 50,125 @ $0 · Grant/award (A): 73,340 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | Leonard Frank X — Chief Executive Officer | Grant/award (A): 150,000 @ $0 · Sale (S): 5,607 @ $13.31 · Grant/award (A): 216,388 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | Cordova Ashley — Former Chief Executive Officer | Tax withholding (F): 17,638 @ $13.30 | EDGAR |
| 2026-03-05 | 4 | Weinberg Uri — Chf Medical and Innovation Ofr | Grant/award (A): 50,125 @ $0 · Sale (S): 6,412 @ $13.31 · Grant/award (A): 73,340 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | DOYLE WILLIAM F — Executive Chairman, Director | Grant/award (A): 200,000 @ $0 · Grant/award (A): 200,284 @ $0 · Sale (S): 50,557 @ $12.79 · Sale (S): 21,330 @ $13.43 · Grant/award (A): 258,445 (derivative) @ $0 · Grant/award (A): 30,072 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Paravasthu Mukund — Chief Operating Officer | Sale (S): 1,555 @ $13.66 · Sale (S): 408 @ $13.49 | EDGAR |
| 2026-03-03 | 4 | Leupin Nicolas — Former Chief Medical Officer | Sale (S): 1,029 @ $13.66 | EDGAR |
| 2026-03-03 | 4 | Puri Michal Nath — Chief Human Resources Officer | Sale (S): 1,441 @ $13.66 | EDGAR |
| 2026-03-03 | 4 | Ben Arye Barak — General Counsel | Grant/award (A): 17,755 @ $0 | EDGAR |
| 2026-03-03 | 4 | Leonard Frank X — Chief Executive Officer | Sale (S): 9,734 @ $13.66 · Grant/award (A): 18,621 @ $0 · Sale (S): 7,232 @ $13.49 | EDGAR |
| 2026-03-03 | 4 | Cordova Ashley — Former Chief Executive Officer | Tax withholding (F): 11,541 @ $13.75 · Grant/award (A): 23,818 @ $0 · Tax withholding (F): 2,410 @ $13.67 · Tax withholding (F): 7,228 @ $13.67 | EDGAR |
| 2026-03-03 | 4 | Weinberg Uri — Chf Medical and Innovation Ofr | Sale (S): 7,461 @ $13.84 · Grant/award (A): 12,992 @ $0 · Sale (S): 3,272 @ $13.33 | EDGAR |
| 2026-01-12 | 4 | Paravasthu Mukund — Chief Operating Officer | Tax withholding (F): 2,133 @ $14.35 | EDGAR |
| 2025-11-04 | 4 | Brackmann Christoph — Chief Financial Officer | Tax withholding (F): 7,033 @ $12.23 | EDGAR |
| 2025-11-04 | 4 | Paravasthu Mukund — Chief Operating Officer | Tax withholding (F): 168 @ $12.81 · Tax withholding (F): 2,949 @ $12.23 | EDGAR |
| 2025-11-04 | 4 | Puri Michal Nath — Chief Human Resources Officer | Tax withholding (F): 752 @ $12.82 | EDGAR |
| 2025-11-04 | 4 | Leonard Frank X — EVP, Pres., Novocure Oncology | Tax withholding (F): 966 @ $12.81 | EDGAR |
| 2025-09-08 | 4 | Cordova Ashley — Chief Executive Officer | Purchase (P): 81,550 @ $12.22 | EDGAR |
| 2025-07-30 | 4 | Brackmann Christoph — Chief Financial Officer | Purchase (P): 10,000 @ $11.63 · Purchase (P): 5,000 @ $11.60 · Purchase (P): 5,000 @ $11.50 | EDGAR |
| 2025-07-01 | 4 | Puri Michal Nath — Chief Human Resources Officer | Grant/award (A): 833 @ $15.13 | EDGAR |
| 2025-07-01 | 4 | Leonard Frank X — EVP, Pres., Novocure Oncology | Grant/award (A): 833 @ $15.13 | EDGAR |
| 2025-07-01 | 4 | Danziger Asaf — Director | Grant/award (A): 833 @ $15.13 | EDGAR |
| 2025-07-01 | 4 | Cordova Ashley — Chief Executive Officer | Grant/award (A): 833 @ $15.13 | EDGAR |
| 2025-07-01 | 4 | Ben Arye Barak — General Counsel | Grant/award (A): 769 @ $15.13 | EDGAR |
| 2025-06-06 | 4 | Stafford Kristin — Director | Grant/award (A): 11,215 @ $0 · Grant/award (A): 16,697 (derivative) @ $0 | EDGAR |
Recent 8-K events — NovoCure Ltd
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-30 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-24 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-09 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-26 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-24 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NVCR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →